Physician profile
Zaw Min
NPI 1649255373
$1,109.08
in general payments reported to CMS, 2019-2025
18 companies · $32.85 in 2025
The $32.85 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $132 · 2021: $294 · 2022: $365 · 2023: $228 · 2024: $56.94 · 2025: $32.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $216.90 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $159.63 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Dexcom, INC. | $139.37 | 2021-2022 | |
| Abbvie INC. | $112.08 | 2021-2023 | |
| Pfizer INC. | $88.96 | 2021-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $65.50 | 2022 | |
| Glaxosmithkline, LLC. | $59.78 | 2023 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $47.54 | 2021 | |
| Lilly USA, LLC | $33.61 | 2020 | |
| Sanofi-Aventis U.S. LLC | $29.02 | 2022 | |
| Abbott Laboratories | $28.20 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.45 | 2022 | |
| Mylan Specialty L.P. | $19.15 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.96 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.72 | 2024 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.00 | 2020 | |
| Idorsia Pharmaceuticals US INC | $15.59 | 2023 | Quviviq |
| Nevro Corp. | $13.62 | 2023 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaw Min listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.